TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
Ke Li(Nanchang University), Zhuowei Hu(Capital Normal University), Shuang Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenbin Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Hua(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinmei Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaojiao Yu(Fujian Medical University), Bing Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Tingting Zhang(Affiliated Hospital of Jining Medical University), Xiaowei Zhang(Central Hospital of Zibo), Shanshan Liu(Guangdong Province Women and Children Hospital), Xia Li(Shanghai Polytechnic University), Bo Huang(Guangdong Pharmaceutical University), Xiaoxi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Feng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Mingzhe Han(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 112
Related Papers
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
|Oncotarget|2017|632
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374